Clincosm LogoSign in Get a demo

neuroendocrine neoplasms

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Neuroendocrine Neoplasms
  • BI 764532
  • +3 more
  • (no location specified)
Nov 10, 2023

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • BI 764532
  • [89Zr]Zr-BI 764532
  • (no location specified)
Jul 31, 2023

Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Neuroendocrine Neoplasms
  • BI 764532
  • (no location specified)
May 22, 2023

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • (no location specified)
May 25, 2023

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)

Terminated
Has Results
  • Neuroendocrine Tumors
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2020